Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00129493 · ClinicalTrials.gov registry record · NA

Group Visits to Improve Hypertension Management

A NA study of Hypertension, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
300
Enrollment target
2
Study locations

NCT00129493 is a NA study of Hypertension that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 300 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00129493, a NA study of Hypertension, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target
2
Study locations

Study Summary

This study investigates group medical visits as a quality improvement strategy for hypertension. It studies group visits in which patients see their own primary care provider together with other patients who have hypertension. The group visits are intended to enhance the patient's self-efficacy for self-management of their chronic disease (hypertension).

Conditions Studied

Interventions

  • BEHAVIORAL Group medical visits

Study Locations (2)

California

  • VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto

Massachusetts

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2004-02
Est. Completion 2007-08
Phase NA

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00129493

The ClinicalTrials.gov registry entry for NCT00129493 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Group medical visits is the first listed.

NCT00129493 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00129493 about?

NCT00129493 is a clinical study titled "Group Visits to Improve Hypertension Management". This study investigates group medical visits as a quality improvement strategy for hypertension. It studies group visits in which patients see their own primary care provider together with other patients who have hypertension. The group visits are intended to enhance the patient's self-efficacy for ...

What is the current status of trial NCT00129493?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2004-02. Estimated completion is 2007-08.

What conditions does trial NCT00129493 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT00129493?

The interventions under investigation include: Group medical visits (BEHAVIORAL).

Who is sponsoring clinical trial NCT00129493?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00129493 being conducted?

This trial has 2 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.